AnGes, Inc. (4563) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROE of 0%

The company has reported losses. Due to this company has reported negative ROE

Poor long term growth as Net Sales has grown by an annual rate of 22.17% and Operating profit at -182.05% over the last 5 years

Positive results in Jun 25

Risky - Negative EBITDA

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 31,782 Million (Small Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.81

Return on Equity

-256.20%

Price to Book

9.34

Revenue and Profits:

Net Sales:

246 Million

(Quarterly Results - Jun 2025)

Net Profit:

-2,718 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-34.04%

6 Months

-8.82%

1 Year

19.23%

2 Years

-19.48%

3 Years

-53.38%

4 Years

-84.06%

5 Years

-95.18%

AnGes, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

AnGes, Inc. Hits Day High with 8.64% Surge in Strong Intraday Performance

AnGes, Inc. has seen a notable rise in stock performance, gaining 8.64% on October 30, 2025, with an intraday high of JPY 89.00. The company has outperformed the Japan Nikkei 225 over the past year, despite facing challenges such as negative return on equity and a history of losses.

AnGes, Inc. Hits Day High with 11.25% Surge in Stock Price

AnGes, Inc. has seen a notable increase in stock performance, achieving an intraday high amid a rising market. Over the past year, the company has outperformed the Nikkei index, despite facing challenges in long-term growth and profitability. Recent results show improved net profit and reduced raw material costs.

AnGes, Inc. Hits Day High with 8.75% Surge in Strong Intraday Performance

AnGes, Inc. has seen a notable rise in its stock performance, reaching an intraday high and outperforming the Japan Nikkei 225 index. Despite recent fluctuations and challenges, including a negative return on equity, the company reported improved financial results, indicating operational progress.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

22.17%

EBIT Growth (5y)

-182.05%

EBIT to Interest (avg)

-9,928.05

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.78

Sales to Capital Employed (avg)

0.07

Tax Ratio

1.93%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

6.91

EV to EBIT

-2.50

EV to EBITDA

-3.70

EV to Capital Employed

28.46

EV to Sales

28.20

PEG Ratio

Dividend Yield

ROCE (Latest)

-1138.21%

ROE (Latest)

-239.01%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 45.21% vs -1.63% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -117.82% vs 94.05% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "245.70",
          "val2": "169.20",
          "chgp": "45.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1,121.40",
          "val2": "-1,252.80",
          "chgp": "10.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2,718.20",
          "val2": "-1,247.90",
          "chgp": "-117.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4,659.40%",
          "val2": "-7,418.30%",
          "chgp": "275.89%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 320.65% vs 128.02% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -278.20% vs 49.45% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "643.60",
          "val2": "153.00",
          "chgp": "320.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5,737.80",
          "val2": "-8,858.40",
          "chgp": "35.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-20,105.80",
          "val2": "-1,820.20",
          "chgp": "-1,004.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-28,129.00",
          "val2": "-7,437.60",
          "chgp": "-278.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-14,153.10%",
          "val2": "-78,226.60%",
          "chgp": "6,407.35%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

245.70

169.20

45.21%

Operating Profit (PBDIT) excl Other Income

-1,121.40

-1,252.80

10.49%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-2,718.20

-1,247.90

-117.82%

Operating Profit Margin (Excl OI)

-4,659.40%

-7,418.30%

275.89%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 45.21% vs -1.63% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -117.82% vs 94.05% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

643.60

153.00

320.65%

Operating Profit (PBDIT) excl Other Income

-5,737.80

-8,858.40

35.23%

Interest

0.00

Exceptional Items

-20,105.80

-1,820.20

-1,004.59%

Consolidate Net Profit

-28,129.00

-7,437.60

-278.20%

Operating Profit Margin (Excl OI)

-14,153.10%

-78,226.60%

6,407.35%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 320.65% vs 128.02% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -278.20% vs 49.45% in Dec 2023

All Annual Results

Company CV

About AnGes, Inc.

AnGes, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

AnGes, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

MarketsMojo — Loved in India, Now Global

Dashboard

Poor Management Efficiency with a low ROE of 0%

Poor long term growth as Net Sales has grown by an annual rate of 22.17% and Operating profit at -182.05% over the last 5 years

Positive results in Jun 25

Risky - Negative EBITDA

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

AnGes, Inc. Hits Day High with 8.64% Surge in Strong Intraday Performance

AnGes, Inc. Hits Day High with 11.25% Surge in Stock Price

AnGes, Inc. Hits Day High with 8.75% Surge in Strong Intraday Performance

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About AnGes, Inc.

Company Coordinates